Sign inJoin waitlistJoin the waitlist

Rebecca Miksad

Chief Medical Officer

Credentials: · · · · · ·

History

Boston University Chobanian & Avedisian School of Medicine · Boston Medical Center
Present

Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training
Cornell University
2001
Harvard University

Research

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
Journal of Clinical Oncology · 2015 · 2,348 citations
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
Journal of Clinical Oncology · 2009 · 388 citations
cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
Case report · Hepatology · 2018 · 283 citations

Andrea Bullock
11 papers
Jennifer Tseng
8 papers
CF
Charles Fuchs
7 papers
Thomas Abrams
7 papers
AA
Amy Abernethy
6 papers
Anand Mahadevan
6 papers
AZ
Andrew Zhu
6 papers
Cary Gross
6 papers · 2 as a resident
SK
Sean Khozin
6 papers
DS
Deb Schrag
5 papers
JC
Jeffrey Clark
5 papers
Jeffrey Meyerhardt
4 papers

Grants

Optimizing Localized Therapy for Primary Liver Cancer: A Clinical Trial and Model
National Cancer Institute · K23
Contact PI · $846.5K · Beth Israel Deaconess Medical Center
2009–2015

Clinical trials

Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
2004–2011